Influx Healthtech P/B Ratio

Current P/B Ratio
6.89
High Valuation
Very High - Significant premium, high growth expectations or speculative

Influx Healthtech (INFLUX) P/B ratio is 6.89 (High), book value per share ₹43.91 vs Healthcare average P/B of -0.31 — Very High - Significant premium, high growth expectations or speculative. View Influx Healthtech 52-week for the annual high/low range and current price position.

Current Valuation Metrics

P/B Ratio 6.89
Current Price
Book Value/Share ₹43.91
Exchange None

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹101 Cr
Share Capital ₹23 Cr
Reserves & Surplus ₹78 Cr
Outstanding Shares 23,000,000
Book Value per Share ₹43.91

Valuation Signal

Signal Overvalued

Sector Context

Sector Average -0.31
Sector Median 0.57
Sector Rank #11 of 50
Sector Percentile 22.0%

INFLUX P/B Ratio — Valuation Insights & Book Value Analysis

Influx Healthtech price-to-book ratio interpretation, valuation status and historical context — current P/B 6.89 (High). Review INFLUX earnings valuation to evaluate earnings-based valuation against sector peers.

  • Stock appears overvalued with PB of 6.89, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Trading at premium to sector average PB of -0.31

INFLUX vs Healthcare Peers — P/B Ratio Comparison

Influx Healthtech P/B 6.89 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.

Sector Average
-0.31
Sector Median
0.57
Lowest P/B
-14.47
Highest P/B
1.1
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -14.47 ₹18 Low
Span Divergent SDL -6.32 ₹19 Low
Parmax Pharma PARMAX -5.61 ₹39 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.22 ₹72 Low
Krebs Biochemicals & Ind… KREBSBIO -0.71 ₹115 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.5 ₹44 Low